FDA approves new sunscreen ingredients for first time in 20 years

An illustration showing a tube of SPF 50 sun cream on a sunny beach during the heatwave in Trez Bellec beach in Telgruc-sur-mer in Finistere in Brittany in France on 25 May 2026. (Photo by Maud Dupuy / Hans Lucas / AFP via Getty Images)
An illustration showing a tube of SPF 50 sun cream on a sunny beach during the heatwave in Trez Bellec beach in Telgruc-sur-mer in Finistere in Brittany in France on 25 May 2026. (Photo by Maud Dupuy / Hans Lucas / AFP via Getty Images)

OAN Staff Jenna Lee
6:30 PM – Tuesday, June 9, 2026

The U.S. Food and Drug Administration (FDA) announced that bemotrizinol — a highly photostable sunscreen agent — has been added to its list of permitted active sunscreen ingredients, marking a major advancement in sun protection as the first new ultraviolet (UV) filter approved for the U.S. market since the late 1990s.

The FDA finalized the decision on Tuesday, roughly seven months after initially issuing the proposed order while skin care experts celebrated the decision. They noted that the regulatory milestone will drastically change how American sunscreens are formulated.

“This is exactly the kind of progress we can achieve when we modernize our processes and apply sound science to regulatory decisions. The FDA is committed to ensuring the American consumer has access to the most effective and safe therapies, including over-the-counter products like sunscreens,” said Mike Davis, M.D., Ph.D., Acting Director of the FDA Center for Drug Evaluation and Research (CDER).

Bemotrizinol, a broad-spectrum UV blocker widely used in Europe and Asia, has been unavailable to American manufacturers until now. The filter protects users from both ultraviolet A (UVA) and ultraviolet B (UVB) rays and is absorbed through the skin into the body at a negligible rate.

 

“With bemotrizinol, you can reduce the number of filters and reduce the total percentage of filters, and that helps you get to a more elegant feeling product,” said chemist Kelly Dobos.

The decades-long delay is largely attributed to the country’s classification of sunscreen ingredients as over-the-counter drugs rather than cosmetics, the standard approach in most other countries. Consequently, obtaining U.S. approval requires significantly more rigorous, lengthy and expensive testing.

Advocacy groups and medical professionals alike view the approval as a major step forward for public health.

 

“This approval is a huge step for patients. The addition of this sunscreen filter allows US manufacturers to formulate in a cosmetically elegant way and the products will begin to achieve the look and feel of all the European and Japanese sunscreens that have gone viral,” said Kavita Mariwalla, MD, FAAD, a double board-certified dermatologist, Mohs surgeon and current president of the American society for Dermatologic Surgery (ASDS).

“This is a great day for American consumers and everyone who has fought to improve sunscreen options. For decades, Americans have used outdated sunscreen tech while the rest of the world moved forward. The approval of bemotrizinol will help change that,” said David Andrews, chief science officer at the nonprofit, Environmental Working Group.

The FDA stated that bemotrizinol is generally recognized as safe and effective (GRASE) for use by adults and children six months and older.

 

Stay informed! Receive breaking news alerts directly to your inbox for free. Subscribe here. https://www.oann.com/alerts 

 

What do YOU think? Click here to jump to the comments!

 

Sponsored Content Below

 

Share this post!